Watch Private Equity Zombies Expected to Multiply as Deal Lull Drags

The Split-Screen

The data points do not agree on direction. That is the story.

• WSJ: Eide Bailly accepts PE capital at $1.8B. A traditional accounting firm sells a stake. Capital is deploying at scale.

• Bloomberg: PE-backed zombies — companies unable to exit or raise — will multiply as the deal lull drags. Capital is stalled at the exit.

• FT: PE bosses turn to carried interest loans as payouts stall. Fund managers are borrowing against their own future carry to fund current compensation. That is not a liquidity signal. That is a paper-wealth signal.

Both reads can be true simultaneously. The PE market is no longer a single market. When a GP levers personal carry, fund IRR math holds on paper while cash distributions to LPs have stopped. That pressure transmits directly into portfolio company budgets. Add-ons slow. Follow-on tranches get re-underwritten.

What Operators Should Audit

If a PE sponsor sits on your cap table, three items deserve review this quarter:

• Hold-period position. Inside the fund's stated exit window, or past it? Late-window companies get less add-on capital and slower follow-on rounds.

• Sponsor liquidity profile. Carried interest lending is a tell. The GP is borrowing against future carry because distributions have stalled. Expect tighter approval cycles on add-ons and pressure on management fees.

• AI repricing risk. If 70% of PE tech deal value compressed on AI disruption, per Goodreturns, your next valuation event will be marked against that curve, not 2021 comparables.

Verdict

The PE cycle is bifurcating, not breaking. Eide Bailly-type deals at premium valuations continue to clear. Everything else compounds into the zombie bucket. For operators, the signal is binary: document your AI exposure now, price the next round assuming a broke-and-patient sponsor, and stop underwriting the old exit math.